PET imaging for nonischemic cardiomyopathy
This trial uses a special PET scan to look at heart tissue in people with nonischemic cardiomyopathy. The scan may help doctors better understand the condition and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old.
- You have been diagnosed with nonischemic cardiomyopathy, which means your heart muscle disease is not caused by blocked arteries.
- You are willing to sign a consent form and follow all study procedures.
- You are not pregnant or breastfeeding.
- You are not severely claustrophobic (fear of enclosed spaces) since you must go inside a scanner.
- You have no known heart disease caused by blocked arteries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of PET scan using a special tracer called Al18F-NOTA-FAPI-04 to see if it can better detect cancer, heart disease, or immune system conditions. The goal is to find out how well this imaging method works for diagnosis or monitoring of these diseases.
This trial uses a special PET scan tracer to see if it can help find and monitor diseases linked to a protein called FAP. It is for both cancer patients needing a biopsy and healthy volunteers.
This study tests a new imaging agent that helps doctors see amyloid buildup in the heart using a PET scan. It may help diagnose cardiac amyloidosis more accurately and guide treatment decisions.
This study uses a special PET scan to look for scarring (fibrosis) in the heart muscle of people with heart failure. It may help doctors better understand why some hearts get stiff or weak.
This study tests a new PET imaging agent that may help doctors see amyloid buildup in the heart more clearly. It may help people with heart amyloidosis or those suspected of having it.
This study uses a special PET/CT scan to look for inflammation in the artery walls of the heart. It will help doctors understand how inflammation relates to coronary artery disease and recent heart attacks.
Hear when a new Nonischemic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.